Retatrutide is the first triagonist that we're heading to the market with, which were hoping sets a new standard in weight loss and patient benefit. TIDES Europe Nov 3, 2026 TO Nov 5, 2026 | Amsterdam, Netherlands Europe's largest and most comprehensive oligonucleotide and peptide therapeutics event featuring scientific breakthroughs, manufacturing innovations, and regulatory insights
So if you dont have enough protein, youre not going to have good thyroid function
Expect results without lifestyle changes - While GLP-1 medications reduce appetite, meaningful weight loss typically requires dietary adjustments and increased physical activity
Eur J Nucl Med Mol Imaging 48:31873197 Stengel A, Malek N, Zipfel S, Goepel S (2021) Long haulersWhat is the evidence for post-covid fatigue
Alternatives to weight loss drugs if diet and exercise havent worked in the past include surgery